Patents by Inventor Elia Bari

Elia Bari has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240148942
    Abstract: A scaffold for bone regeneration comprises a three-dimensional support structure made with a composite hybrid formed by a bovine bone-derived matrix reinforced with a polymer and containing collagen fragments; the support structure is functionalized with secretome, in particular mesenchymal stem cell secretome, in lyophilized form (lyosecretome).
    Type: Application
    Filed: March 9, 2022
    Publication date: May 9, 2024
    Inventors: Elia Bari, Giuseppe Perale, Sara Perteghella, Marzio Sorlini, Maria Luisa Torre
  • Publication number: 20240148936
    Abstract: A scaffold for tissue regeneration, particularly for bone regeneration, comprises a three-dimensional supporting structure made of a biocompatible and biodegradable material; the supporting structure is functionalized with secretome, in particular mesenchymal stem cell secretome, preferably in lyophilized form (lyosecretome).
    Type: Application
    Filed: March 9, 2022
    Publication date: May 9, 2024
    Applicant: PHARMAEXCEED S.R.L.
    Inventors: Ferdinando Auricchio, Elia Bari, Michele Conti, Sara Perteghella, Franca Scocozza, Marzio Sorlini, Maria Luisa Torre
  • Publication number: 20220249656
    Abstract: The present patent application relates to nanoparticles for the delivery and targeting of a non-tumour-specific antigen in cancer cells, comprising a matrix support based on a biocompatible material, the non-tumour-specific antigen, and an adjuvant, for use in recalling, in cancer patients who have a specific immunity for the non-tumour-specific antigen pre-existing to the tumour pathology, the immune response specific to the non-tumour-specific antigen against the cancer cells. A further object of the application is anti-tumour pharmaceutical formulations comprising nanoparticles and kits comprising the aforementioned anti-tumour pharmaceutical formulations in combination with traditional anti-tumour vaccines.
    Type: Application
    Filed: June 10, 2020
    Publication date: August 11, 2022
    Applicants: PHARMAEXCEED S.R.L.
    Inventors: Gilberto Filaci, Daniela Fenoglio, Francesca Ferrera, Maria Luisa Torre, Elia Bari, Sara Perteghella